Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up

NCT03097445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2020-01-23

No results posted yet for this study

Summary

This study will perform a 5-year follow-up survey of participants in a randomized controlled trial that evaluated the effectiveness of providing 5 weeks of free NRT (in the form of the nicotine patch) by expedited postal mail without behavioural assistance to regular adult smokers recruited across Canada interested in receiving it (clinicaltrials.gov Identifier: NCT01429129).

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine patch

mailed 5-week course of Habitrol® transdermal nicotine patches

Sponsors & Collaborators

  • Canadian Cancer Society (CCS)

    collaborator OTHER
  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • John Cunningham, PhD · Centre for Addiction and Mental Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-04
Primary Completion
2019-08-22
Completion
2019-08-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03097445 on ClinicalTrials.gov